Toposar is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Teva Parenteral Medicines, Inc.. The primary component is Etoposide.
Product ID | 0703-5653_5a15357e-ee28-4f39-998c-f5f18a94db13 |
NDC | 0703-5653 |
Product Type | Human Prescription Drug |
Proprietary Name | Toposar |
Generic Name | Etoposide |
Dosage Form | Injection, Solution, Concentrate |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 1996-08-01 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA074529 |
Labeler Name | Teva Parenteral Medicines, Inc. |
Substance Name | ETOPOSIDE |
Active Ingredient Strength | 20 mg/mL |
Pharm Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 1996-08-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA074529 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1996-08-01 |
Ingredient | Strength |
---|---|
ETOPOSIDE | 20 mg/mL |
SPL SET ID: | c9080cf5-4fc3-4cf9-a241-6e40a6fddc75 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0703-5653 | Toposar | Etoposide |
0703-5656 | Toposar | Etoposide |
0703-5657 | Toposar | Etoposide |
0143-9376 | Etoposide | Etoposide |
0143-9510 | Etoposide | Etoposide |
0143-9511 | Etoposide | Etoposide |
0143-9512 | Etoposide | Etoposide |
0378-3266 | Etoposide | etoposide |
16729-114 | Etoposide | Etoposide |
16729-262 | Etoposide | Etoposide |
63323-104 | Etoposide | ETOPOSIDE |
68001-265 | Etoposide | Etoposide |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
TOPOSAR 78387063 2968789 Live/Registered |
Sicor, Inc. 2004-03-18 |
TOPOSAR 75307102 2231482 Dead/Cancelled |
INTERMAP TECHNOLOGIES CORPORATION 1997-06-11 |
TOPOSAR 74494615 1940232 Dead/Cancelled |
Erbamont Inc. 1994-02-25 |